Exicure, Inc.
Pharmaceutical company · Chicago, Illinois, United States · Nasdaq: XCUR
Exicure, Inc. is a pharmaceutical company headquartered in Chicago, Illinois, United States. Its earliest recorded incorporation is in 2011. Its shares trade on Nasdaq under the ticker XCUR. It has received 2 US government small-business research awards (SBIR/STTR) from health agencies, $374,876 in total, most recently in 2014. It has reported private securities offerings to the US SEC, most recently $22 million sold in a notice filed in 2018.
What does Exicure do?
US government research funding
2 SBIR/STTR small-business research awards from US health agencies, $374,876 in total (2014).
Private fundraising reported to the SEC
6 Form D notices; the most recent reported $22 million sold (2018).
Frequently asked questions about Exicure
Where is Exicure headquartered?
Exicure, Inc. is headquartered in Chicago, Illinois, United States.
What does Exicure do?
Exicure, Inc. is a pharmaceutical company. Its SEC industry classification is Pharmaceutical Preparations.
Is Exicure a public company?
Yes. Exicure, Inc. trades on Nasdaq under the ticker XCUR.
When was Exicure founded?
The earliest incorporation on record for Exicure, Inc. is in 2011, according to public company registers.
Similar companies
- MAIA Biotechnology, Inc.Chicago, Illinois, United States
- Xeris Pharmaceuticals IncChicago, Illinois, United States
- Bright Minds Biosciences Inc.Chicago, Illinois, United States
- AbbVie Inc.North Chicago, Illinois, United States
- Savara IncAustin, Texas, United States
- Crinetics Pharmaceuticals, Inc.San Diego, California, United States
- Cartesian Therapeutics, Inc.Frederick, Maryland, United States
- Karyopharm Therapeutics Inc.Newton, Massachusetts, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesSources
Location data: GeoNames (geonames.org), CC BY 4.0.
Last updated 2026-09-23.